+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Ertapenem"

Ertapenem Sodium API Market - Global Forecast 2025-2030 - Product Thumbnail Image

Ertapenem Sodium API Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 193 Pages
  • Global
From
From
From
Carbapenem-Based Antibiotics Market - Global Forecast 2025-2030 - Product Thumbnail Image

Carbapenem-Based Antibiotics Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 181 Pages
  • Global
From
From
Carbapenem-Based Antibiotics Market Report 2025 - Product Thumbnail Image

Carbapenem-Based Antibiotics Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
From
From
Carbapenem - Global Strategic Business Report - Product Thumbnail Image

Carbapenem - Global Strategic Business Report

  • Report
  • September 2025
  • 383 Pages
  • Global
From
From
  • 13 Results (Page 1 of 1)
Loading Indicator

Ertapenem is an antibiotic used to treat a variety of bacterial infections. It belongs to a class of antibiotics known as carbapenems, which are broad-spectrum antibiotics used to treat serious infections caused by multiple drug-resistant bacteria. Ertapenem is typically used to treat infections of the urinary tract, skin, and soft tissue, as well as intra-abdominal infections. It is also used to treat bacterial meningitis. Ertapenem is generally well-tolerated and has a low risk of adverse effects. Ertapenem is available in both generic and brand-name formulations. It is typically administered intravenously or intramuscularly, and is available in various dosage forms, including tablets, capsules, and injections. Ertapenem is often used in combination with other antibiotics to treat serious infections. Ertapenem is a widely used antibiotic, and is available from many pharmaceutical companies, including Merck, Pfizer, and Teva Pharmaceuticals. It is also available from generic drug manufacturers such as Mylan and Sandoz. Show Less Read more